1887

Abstract

The pleiotropic cytokine TGF-β1 is a member of a large family of related factors involved in controlling cell proliferation, differentiation and apoptosis. TGF-β ligands interact with a complex of type I and type II transmembrane serine/threonine kinases and they transmit their signals to the nucleus via a family of Smad proteins. A panel of over 20 Burkitt’s lymphoma (BL) cell lines has been compiled including those that are Epstein–Barr virus (EBV) negative, those that carry EBV with a restricted pattern of EBV latent gene expression (group I) and those that express the full range of latent EBV genes (group III), together with selected EBV-transformed lymphoblastoid cell lines (LCLs). Most of the EBV-negative and group I BL cell lines underwent apoptosis or a G arrest in response to TGF-β1 treatment. In contrast, group III cell lines and LCLs were completely refractory to these effects of TGF-β1. All of the cell lines expressed the TGF-β pathway Smads and the TGF-β type I receptor. Lack of responsiveness to TGF-β1 appears to correlate with a down-regulation of TGF-β type II receptor expression. Studies of EBV-converted and stably transfected BL cell lines demonstrated that the EBV gene LMP-1 is neither necessary nor sufficient to block the TGF-β1 response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-6-1567
2000-06-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/6/0811567a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-6-1567&mimeType=html&fmt=ahah

References

  1. Allday, M. J. & Farrell, P. J. ( 1994; ). Epstein–Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells. Journal of Virology 68, 3491-3498.
    [Google Scholar]
  2. Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H. & Farrell, P. J. ( 1995; ). Epstein–Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO Journal 14, 1382-1391.
    [Google Scholar]
  3. Altiok, A., Ehlin-Henriksson, B. & Klein, E. ( 1993; ). Correlation between the growth-inhibitory effect of TGF-beta 1 and phenotypic characteristics in a panel of B-cell lines. International Journal of Cancer 55, 137-140.[CrossRef]
    [Google Scholar]
  4. Amoroso, S. R., Huang, N., Roberts, A. B., Potter, M. & Letterio, J. J. ( 1998; ). Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas. Proceedings of the National Academy of Sciences, USA 95, 189-194.[CrossRef]
    [Google Scholar]
  5. Arvanitakis, L., Yaseen, N. & Sharma, S. ( 1995; ). Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Journal of Immunology 155, 1047-1056.
    [Google Scholar]
  6. Bauer, G., Hofler, P. & Simon, M. ( 1982; ). Epstein–Barr virus induction by a serum factor. Characterization of the purified factor and the mechanism of its activation. Journal of Biological Chemistry 257, 11411-11415.
    [Google Scholar]
  7. Beckwith, M., Ruscetti, F. W., Sing, G. K., Urba, W. J. & Longo, D. L. ( 1995; ). Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: inhibition of growth is associated with a downregulation of mutant p53. Blood 85, 2461-2470.
    [Google Scholar]
  8. Blomhoff, H. K., Smeland, E., Mustafa, A. S., Godal, T. & Ohlsson, R. ( 1987; ). Epstein–Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage. European Journal of Immunology 17, 299-301.[CrossRef]
    [Google Scholar]
  9. Brimmell, M., Mendiola, R., Mangion, J. & Packham, G. ( 1998; ). BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16, 1803-1812.[CrossRef]
    [Google Scholar]
  10. Chaouchi, N., Arvanitakis, L., Auffredou, M. T., Blanchard, D. A., Vazquez, A. & Sharma, S. ( 1995; ). Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11, 1615-1622.
    [Google Scholar]
  11. Cryns, V. & Yuan, J. ( 1998; ). Proteases to die for. Genes & Development 12, 1551-1570.[CrossRef]
    [Google Scholar]
  12. Derynck, R. & Feng, X. H. ( 1997; ). TGF-beta receptor signaling. Biochimica et Biophysica Acta 1333, F105-F150.
    [Google Scholar]
  13. di Renzo, L., Altiok, A., Klein, G. & Klein, E. ( 1994; ). Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. International Journal of Cancer 57, 914-919.[CrossRef]
    [Google Scholar]
  14. Douglas, R. S., Capocasale, R. J., Lamb, R. J., Nowell, P. C. & Moore, J. S. ( 1997; ). Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood 89, 941-947.
    [Google Scholar]
  15. Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H. & Crook, T. ( 1991; ). p53 is frequently mutated in Burkitt’s lymphoma cell lines. EMBO Journal 10, 2879-2887.
    [Google Scholar]
  16. Feng, X. H. & Derynck, R. ( 1996; ). Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. Journal of Biological Chemistry 271, 13123-13129.[CrossRef]
    [Google Scholar]
  17. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H. & Miyazono, K. ( 1993; ). Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75, 681-692.[CrossRef]
    [Google Scholar]
  18. Gauchat, J. F., Gascan, H., de Waal Malefyt, R. & de Vries, J. E. ( 1992; ). Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells. Journal of Immunology 148, 2291-2299.
    [Google Scholar]
  19. Gilboa, L., Wells, R. G., Lodish, H. F. & Henis, Y. I. ( 1998; ). Oligomeric structure of type I and type II transforming growth factor β receptors: homodimers form in the ER and persist at the plasma membrane. Journal of Cell Biology 140, 767-777.[CrossRef]
    [Google Scholar]
  20. Gregory, C. D., Rowe, M. & Rickinson, A. B. ( 1990; ). Different Epstein–Barr virus–B cell interactions in phenotypically distinct clones of a Burkitt’s lymphoma cell line. Journal of General Virology 71, 1481-1495.[CrossRef]
    [Google Scholar]
  21. Gutierrez, M. I., Cherney, B., Hussain, A., Mostowski, H., Tosato, G., Magrath, I. & Bhatia, K. ( 1999; ). Bax is frequently compromised in Burkitt’s lymphomas with irreversible resistance to Fas-induced apoptosis. Cancer Research 59, 696-703.
    [Google Scholar]
  22. Heldin, C.-H., Miyazono, K. & ten Dijke, P. ( 1997; ). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.[CrossRef]
    [Google Scholar]
  23. Jiang, W., Tillekeratne, M. P. M., Brattain, M. G. & Banerji, S. S. ( 1997; ). Decreased stability of transforming growth factor β type II receptor mRNA in RER+ human colon carcinoma cells. Biochemistry 36, 14786-14793.[CrossRef]
    [Google Scholar]
  24. Kaptein, J. S., Lin, C.-K. E., Wang, C. L., Nguyen, T. T., Kalunta, C. I., Park, E., Chen, F.-S. & Lad, P. M. ( 1996; ). Anti-IgM-mediated regulation of c-myc and its possible relationship to apoptosis. Journal of Biological Chemistry 271, 18875-18884.[CrossRef]
    [Google Scholar]
  25. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T. & Miyazono, K. ( 1998; ). Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO Journal 17, 4056-4065.[CrossRef]
    [Google Scholar]
  26. Kehrl, J. H., Taylor, A. S., Delsing, G. A., Roberts, A. B., Sporn, M. B. & Fauci, A. S. ( 1989; ). Further studies of the role of transforming growth factor-beta in human B cell function. Journal of Immunology 143, 1868-1874.
    [Google Scholar]
  27. Kumar, A., Rogers, T., Maizel, A. & Sharma, S. ( 1991; ). Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. Journal of Immunology 147, 998-1006.
    [Google Scholar]
  28. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. & Earnshaw, W. C. ( 1994; ). Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.[CrossRef]
    [Google Scholar]
  29. Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A. & Lodish, H. F. ( 1992; ). Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.[CrossRef]
    [Google Scholar]
  30. Lomo, J., Blomhoff, H. K., Beiske, K., Stokke, T. & Smeland, E. B. ( 1995; ). TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. Journal of Immunology 154, 1634-1643.
    [Google Scholar]
  31. MacDonald, I., Wang, H., Grand, R., Armitage, R. J., Fanslow, W. C., Gregory, C. D. & Gordon, J. ( 1996; ). Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines. Blood 87, 1147-1154.
    [Google Scholar]
  32. Mann, K. P., Staunton, D. & Thorley-Lawson, D. A. ( 1985; ). Epstein–Barr virus-encoded protein found in plasma membranes of transformed cells. Journal of Virology 55, 710-720.
    [Google Scholar]
  33. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B. and others ( 1995; ). Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336–1338.[CrossRef]
    [Google Scholar]
  34. Massagué, J. ( 1998; ). TGF-β signal transduction. Annual Review of Biochemistry 67, 753-791.[CrossRef]
    [Google Scholar]
  35. Milner, A. E., Grand, R. J., Vaughan, A. T., Armitage, R. J. & Gregory, C. D. ( 1997; ). Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation. Oncogene 15, 1815-1822.[CrossRef]
    [Google Scholar]
  36. Milner, A. E., Levens, J. M. & Gregory, C. D. ( 1998; ). Flow cytometric methods of analyzing apoptotic cells. Methods in Molecular Biology 80, 347-354.
    [Google Scholar]
  37. Pokrovskaja, K., Ehlin-Henriksson, B., Bartkova, J., Bartek, J., Scuderi, R., Szekely, L., Wiman, K. G. & Klein, G. ( 1996; ). Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Cell Growth and Differentiation 7, 1723-1732.
    [Google Scholar]
  38. Polyak, K. ( 1996; ). Negative regulation of cell growth by TGF beta. Biochimica et Biophysica Acta 1242, 185-199.
    [Google Scholar]
  39. Rich, B. E. & Steitz, J. A. ( 1987; ). Human acidic ribosomal phosphoproteins P0, P1, and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Molecular and Cellular Biology 7, 4065-4074.
    [Google Scholar]
  40. Rickinson, A. B. & Kieff, E. ( 1996; ). Epstein–Barr virus. In Fields Virology, pp. 2397-2446. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott–Raven.
  41. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H. & Rickinson, A. B. ( 1987; ). Differences in B cell growth phenotype reflect novel patterns of Epstein–Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO Journal 6, 2743-2751.
    [Google Scholar]
  42. Saltzman, A., Munro, R., Searfoss, G., Franks, C., Jaye, M. & Ivashchenko, Y. ( 1998; ). Transforming growth factor-β-mediated apoptosis in Ramos B-lymphoma cell line is accompanied by caspase activation and BclX1 downregulation. Experimental Cell Research 242, 244-254.[CrossRef]
    [Google Scholar]
  43. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
  44. Schrantz, N., Blanchard, D. A., Auffredou, M. T., Sharma, S., Leca, G. & Vazquez, A. ( 1999; ). Role of caspases and possible involvement of retinoblastoma protein during TGFβ-mediated apoptosis of human B lymphoblasts. Oncogene 18, 3511-3519.[CrossRef]
    [Google Scholar]
  45. Schuster, C., Chasserot-Golaz, S. & Beck, G. ( 1991; ). Activation of Epstein–Barr virus promoters by a growth-factor and a glucocorticoid. FEBS Letters 284, 82-86.[CrossRef]
    [Google Scholar]
  46. Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Hoffman, B. & Liebermann, D. ( 1994; ). Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9, 1791-1798.
    [Google Scholar]
  47. Smeland, E. B., Blomhoff, H. K., Holte, H., Ruud, E., Beiske, K., Funderud, S., Godal, T. & Ohlsson, R. ( 1987; ). Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Experimental Cell Research 171, 213-222.[CrossRef]
    [Google Scholar]
  48. Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F. & Taketo, M. M. ( 1998; ). Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656.[CrossRef]
    [Google Scholar]
  49. Takenoshita, S., Hagiwara, K., Nagashima, M., Gemma, A., Bennett, W. P. & Harris, C. C. ( 1996; ). The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII). Genomics 36, 341-344.[CrossRef]
    [Google Scholar]
  50. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. ( 1998; ). Epstein–Barr virus (EBV) in endemic Burkitt’s lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373-1381.
    [Google Scholar]
  51. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. & Massagué, J. ( 1994; ). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.[CrossRef]
    [Google Scholar]
  52. Zhu, Y., Richardson, J. A., Parada, L. F. & Graff, J. M. ( 1998; ). Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-6-1567
Loading
/content/journal/jgv/10.1099/0022-1317-81-6-1567
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error